City Therapeutics Inc (CTY) Stock
Key stats
- Market cap
- $856.15M
- Price / Earnings ratio
- -16.9x
- EPS (TTM)
- -$12.46
- Volume
- Loading
- 52-week high
- $23.88
- 52-week low
- $15.81
Source: third-party data provider, as of November 13, 2026
Recent news

City Therapeutics eyes valuation of up to $956.3 million in US IPO amid biotech listing push
City Therapeutics eyes valuation of up to $956.3 million in US IPO amid biotech listing push
CTY

Drug developer City Therapeutics files for US IPO
Drug developer City Therapeutics files for US IPO
CTY
News tone: automated (AI) classification of the article's content, not a price prediction.
Analyst ratings
Analyst consensus: Buy
Based on 4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
No data available
Source: third-party data provider
Latest news

City Therapeutics eyes valuation of up to $956.3 million in US IPO amid biotech listing push
City Therapeutics eyes valuation of up to $956.3 million in US IPO amid biotech listing push
CTY

Drug developer City Therapeutics files for US IPO
Drug developer City Therapeutics files for US IPO
CTY
News tone: automated (AI) classification of the article's content, not a price prediction.
About City Therapeutics Inc
City Therapeutics is a clinical-stage biotechnology company developing the next generation of RNA interference (“RNAi”) therapeutics designed to silence the expression of disease-relevant proteins, with the aim of delivering meaningful and durable benefits for patients in need. The company believes its deep RNAi expertise and City Platform capabilities uniquely position it to achieve its goal of developing potentially best-in-class therapeutics
Fundamentals
Valuation
Trading
Source: third-party data provider, as of November 13, 2026
Analyst views
4 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $32.00
- Average
- $37.33
- High
- $46.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -7.5 | -18.5 |



